Management of tuberculosis and HIV co-infection in Cotonou, Benin

Medecine et Maladies Infectieuses

Volumn 42, Issue 11, 2012, Pages 561-566

  Agodokpessi, G ^a,b   Ade, G ^a,b   Ade, S ^a   Wachinou, A P ^a   Affolabi, D ^a,b   Anagonou, S ^a,b   Gninafon, M ^a,b  

^a Centre National Hospitalier de Pneumo Phtisiologie   (Benin)

^b UNIVERSITY OF ABOMEY CALAVI   (Benin)

Author keywords

AIDS; Co infection; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BENIN; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SCREENING; SEX RATIO; SPUTUM EXAMINATION; TREATMENT RESPONSE; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; BENIN; CD4 LYMPHOCYTE COUNT; COMORBIDITY; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RETROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS; YOUNG ADULT;

EID: 84869876905     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2012.07.012     Document Type: Article

References (23)

1. World Health Organization. Global tuberculosis control: WHO report 2011. WHO/HTM/TB/2011.16. ISBN 978 92 4 156438 0.
2. Ministère de la santé, direction nationale de la protection sanitaire. Guide de surveillance épidemiologique et de prise en charge de la co-infection tuberculose/VIH au Benin, 1re édition. Cotonou PNT, Septembre 2008; 56 p.
3. Dagnra A.Y., Adjoh K.S., Tchaptchet Heunda S., Patassi A.A., Sadzo Hetsu D., Awokou F., et al. Prevalence of the coinfection VIH-tuberculose and impact de the infection VIH sur the evolution of the tuberculose pulmonaire au Togo. Bull. Soc. Pathol. Exot. 2011, 104:342-346.
4. Tosi C.H., Ndeikoundam Ngangro M., Djimadoum N., Richard V. Surveillance de la séroprévalence du VIH chez les patients atteints d'une tuberculose pulmonaire en 1999 au Tchad. Med Trop 2002, 62:627-633.
5. Ministère de la santé, direction nationale de la santé publique, Programme national de lutte contre le sida. Rapport de Surveillance de l'infection à VIH et de la syphilis au Benin. Cotonou, PNLS, février 2011, 45 p.
6. Perlman D.C., El Sadr W.M., Nelson A.N.D. Variation of Chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Clin Infect Dis 1997, 25:242-246. The AIDS Clinical Trials Group (ACTG).
7. Jones B.E., Young S.M., Antoniskis D., Davidson P.T., Kramer F., Barner P.F. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 1993, 148:1292-1297.
8. Teck R., Ascurra O., Gomani P., Manzi M., Pasulani O., Kusamale J., et al. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for anti-retroviral treatment: relationship to CD4-lymphocyte counts. Int J Tuberc Lung Dis 2005, 9:258-282.
9. Kumwenda M., Tom S., Chan A.K., Mwinjiwa E., Sodhi S., Joshua M., et al. Reasons for accepting or refusing HIV services among tuberculosis patients at a TB-HIV integration clinic in Malawi. Int J Tuberc Lung Dis 2011, 15:1663-1669.
10. Takarinda K.C., Harries A.D., Srinath S., Mutasa-Apollo T., Sandy C., Mugurungi O. Treatment outcomes of adult patients with recurrent tuberculosis in relation to HIV status in Zimbabwe: a retrospective record review. BMC Pub Health 2012, 13(12):124.
11. Ifebunandu N.A., Ukwaja K.N., Obi S.N. Treatment outcome of HIV-associated tuberculosis in a resource-poor setting. Trop Doct 2012, 42:74-76.
12. Liberato I.R., De Albuquerque M.D.E.F., Campelo A.R., De Melo H.R. Characteristics of pulmonary tuberculosis in HIV seropositive and seronegative patients in a Northeastern region of Brazil. Rev Soc Bras Med Trop 2004, 37:46-50.
13. Gninafon M., Tawo L., Kassa F., Monteiro G.P., Zellweger J.P., Shang H., et al. Outcome of tuberculosis retreatment in routine conditions in Cotonou, Benin. Int J Tuberc Lung Dis 2004, 8(10):1242-1247.
14. Horo K., N'Gom S.A., Kouassi A.B., Djebi H.I., Gnaze A.Z., Toure K., et al. Tuberculose et genre à Abidjan. Rev Pneumol Top 2010, 13:70-81.
15. Bashour H., Mamaree F. Gender differences and tuberculosis in the Syrian Arab Republic: patients' attitudes, compliance and outcomes. East Mediterr Health J 2003, 9:757-768.
16. Santha T., Garg R., Frieden T.R., et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002, 6:780-788.
17. Mungrue K., Beharry A., Kalloo J., Mahabir S., Maraj T., Ramoutar R., et al. Trends in HIV/TB co-infection in Trinidad and Tobago for the period 1998-2007. J Int Assoc Physicians AIDS Care 2009, 8:170-175.
18. Salim S.A.K., Kogieleum N., Anneke G., Nesri P., Cheryl B., Andrew G.T., et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010, 362:697-706.
19. Kwara B., Flanigan T.P., Carter E.J. Le treatment antiretroviral à haute activité (HAART) chez les adultes tuberculeux : état actuel. Int J Tuberc Lung Dis 2005, 9:248-257.
20. OMS. Politique actuelle de collaboration pour les activites de lutte contre la tuberculose and le VIH. Geneve, Organisation mondiale of the sante, 2004 (WHO/HTM/TB/2004.330; WHO/HTM/HIV/2004.1).
21. Zolopa A., Andersen J., Powderly W., Sanchez A., Sanne I., Suckow C., et al. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS One 2009, 4:e5575.
22. Girardi E., Sabin C.A., Monforte A.A., Hogg B., Phillips A.N., Gill M.J., et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. CID 2005, 41:1772-1782.
23. Vijay S., Kumar P., Chauhan L.S., Rao S.V., Vaidyanathan P. Treatment outcome and mortality at one and half year follow-up of HIV infected TB patients under TB control programme in a district of South India. PLoS One 2011, 6:e21008.